As of 2024-09-19, the Relative Valuation of Acceleron Pharma Inc (XLRN) is (108.90) USD. This relative valuation is based on P/E multiples. With the latest stock price at 178.75 USD, the upside of Acceleron Pharma Inc based on Relative Valuation is -160.9%.
The range of the Relative Valuation is (108.22) - (99.44) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 25.6x - 45.9x | 29.0x |
| Forward P/E multiples | 20.1x - 23.6x | 22.6x |
| Fair Price | (108.22) - (99.44) | (108.90) |
| Upside | -160.5% - -155.6% | -160.9% |
| Date | P/E |